Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clínic Barcelona, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain.
Bipolar Disord. 2011 Mar;13(2):145-54. doi: 10.1111/j.1399-5618.2011.00908.x.
The aim of this study was to elucidate the factors associated with the occurrence of mixed episodes, characterized by the presence of concomitant symptoms of both affective poles, during the course of illness in bipolar I disorder patients treated with an antidepressant, as well as the role of antidepressants in the course and outcome of the disorder.
We enrolled a sample of 144 patients followed for up to 20 years in the referral Barcelona Bipolar Disorder Program and compared subjects who had experienced at least one mixed episode during the follow-up (n=60) with subjects who had never experienced a mixed episode (n=84) regarding clinical variables.
Nearly 40% of bipolar I disorder patients treated with antidepressants experienced at least one mixed episode during the course of their illness; no gender differences were found between two groups. Several differences regarding clinical variables were found between the two groups, but after performing logistic regression analysis, only suicide attempts (p<0.001), the use of serotonin norepinephrine reuptake inhibitors (p=0.041), switch rates (p=0.010), and years spent ill (p=0.022) were significantly associated with the occurrence of at least one mixed episode during follow-up.
The occurrence of mixed episodes is associated with a tendency to chronicity, with a poorer outcome, a higher number of depressive episodes, and greater use of antidepressants, especially serotonin norepinephrine reuptake inhibitors.
本研究旨在阐明在接受抗抑郁药治疗的单相 I 型双相情感障碍患者的疾病病程中,出现混合发作(即同时存在两种情感极端的症状)的相关因素,以及抗抑郁药在疾病病程和结局中的作用。
我们纳入了在巴塞罗那双相情感障碍项目中接受了长达 20 年随访的 144 例患者作为研究样本,并比较了在随访期间至少经历过一次混合发作的(n=60)和从未经历过混合发作的(n=84)患者的临床变量。
近 40%的接受抗抑郁药治疗的单相 I 型双相情感障碍患者在疾病病程中经历过至少一次混合发作;两组间未发现性别差异。两组间存在多项临床变量差异,但在进行逻辑回归分析后,仅自杀企图(p<0.001)、使用 5-羟色胺去甲肾上腺素再摄取抑制剂(p=0.041)、转换率(p=0.010)和患病年限(p=0.022)与随访期间至少发生一次混合发作显著相关。
混合发作的发生与慢性化趋势、较差的结局、更多的抑郁发作和更频繁地使用抗抑郁药(特别是 5-羟色胺去甲肾上腺素再摄取抑制剂)相关。